Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Evaluation of Efficacy and Safety of FOLFIRI Association Treatment in Patients 70 Years of Age and Older With Gastric Cancer (CEPAFIRI)

This study has been completed.
Sponsor:
Collaborators:
Novartis
Sanofi-Synthelabo
Aventis Pharmaceuticals
Information provided by:
Institut Bergonié
ClinicalTrials.gov Identifier:
NCT00210184
First received: September 13, 2005
Last updated: December 29, 2011
Last verified: October 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: July 2009
  Estimated Primary Completion Date: No date given